Project Grant R21HD117132
Award Date
7/23/25
Completion Date
6/30/27
Dollars Obligated
$450K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award of $1,107,090, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, supports research at The General Hospital Corporation (doing business as Massachusetts General Hospital) to investigate the regulation of G protein alpha subunit (Gsα) expression and its role in hormone signaling. The research aims to elucidate the mechanisms by which GNAS gene...
This federal Project Grant award of $189,056 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research by Neurosant Therapeutics LLC to develop therapeutics that can correct the underlying genetic cause of Smith-Magenis Syndrome (SMS). The key goals of the project are to demonstrate that the expression of the RAI1 gene, which is reduced in SMS due to a genetic deletion,...
The National Institute of Child Health and Human Development (NICHD) awarded a $295,923 Project Grant to Biostrategies LC under the Child Health and Human Development Extramural Research program (CFDA 93.865). The purpose of the award is to develop a "delivery-enhanced" gene therapy drug comprising an RTB:GALNS fusion protein for treating the rare metabolic disorder Mucopolysaccharidosis Type IVA (Morquio A Syndrome). The key objectives are to: 1) optimize the RTB:GALNS construct for...
This federal Project Grant award of $2,442,535 was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The goal of this 5-year project is to provide critically-needed evidence on how to implement newborn genomic sequencing, manage findings, and reanalyze data to ensure it provides lifelong benefits to individuals and advances public health. The key...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the federal Child Health and Human Development Extramural Research program (CFDA 93.865), provides $466,332 to Loyola University of Chicago to develop a novel strategy using locked nucleic acid (LNA) site-blocking antisense oligonucleotides (SBASOs) to increase expression of the MECP2 gene and potentially reverse symptoms of Rett syndrome. The key goals are to...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $130,680 Project Grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) for the period of July 1, 2025 to June 30, 2027. The grant will fund the development of robust computational technologies for single-cell functional genomics, enabling the comprehensive identification of genetic variants (SNPs) that regulate tissue niches...
This federal Project Grant award of $249,000 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to identify new therapeutics and understand molecular mechanisms for Congenital Disorders of Glycosylation (CDGs). The key objectives are to: 1) Determine the mechanisms of modifier genes that can rescue a DPAGT1-CDG cell model, 2) Conduct a drug repurposing screen in a DPAGT1-CDG...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is focused on elucidating the mechanisms underlying the pathogenesis of Hao-Fountain Syndrome, a rare genetic disease caused by USP7 variants. The $456,892 award, effective from August 1, 2025 to July 31, 2027, will support research to investigate the effect of Hao-Fountain Syndrome variants on the ERK1/2...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research to integrate genetic and socio-environmental factors to predict disease progression. The $138,499 award to The General Hospital Corporation (doing business as Massachusetts General Hospital) aims to develop statistical models that leverage genetic, longitudinal healthcare, and socio-environmental data to enhance precision medicine for 16 exemplar disease...
This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research program supports a 5-year research project focused on pharmacogenomic factors impacting the biotransformation and precision dosing of the drug trihexyphenidyl (THP) for children with dystonia and cerebral palsy. The $164,160 award aims to: 1) Determine how CYP2D6 and CYP2C19 genotypes affect...